These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34785927)

  • 1. Predicting Neoadjuvant Chemoradiotherapy Response in Locally Advanced Rectal Cancer Using Tumor-Infiltrating Lymphocytes Density.
    Xu Y; Lou X; Liang Y; Zhang S; Yang S; Chen Q; Xu Z; Zhao M; Li Z; Zhao K; Liu Z
    J Inflamm Res; 2021; 14():5891-5899. PubMed ID: 34785927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of the tumour-stroma ratio for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer: a case control study.
    Liang Y; Zhu Y; Lin H; Zhang S; Li S; Huang Y; Liu C; Qu J; Liang C; Zhao K; Li Z; Liu Z
    BMC Cancer; 2021 Jun; 21(1):729. PubMed ID: 34172021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive Value of the Neutrophil-Lymphocyte Ratio for Tumor Regression Grade and Prognosis of Local Advanced Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
    Li S; Wang D; Wei R; Yu G; Wang X; Jiang Z
    Technol Cancer Res Treat; 2023; 22():15330338231202611. PubMed ID: 37807729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-Infiltrating Lymphocytes in Biopsy Specimens Obtained 7 Days after Starting Chemoradiotherapy for Rectal Cancer Are Predictors of the Response to Chemoradiotherapy.
    Miyakita H; Sadahiro S; Suzuki T; Chan LF; Ogimi T; Okada K; Yamamoto S; Kajiwara H
    Oncology; 2020; 98(12):869-875. PubMed ID: 32799200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-infiltrating lymphocytes, forkhead box P3, programmed death ligand-1, and cytotoxic T lymphocyte-associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer.
    Teng F; Meng X; Kong L; Mu D; Zhu H; Liu S; Zhang J; Yu J
    Transl Res; 2015 Dec; 166(6):721-732.e1. PubMed ID: 26209749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].
    Shu Z; Fang S; Ding Z; Mao D; Pang P; Gong X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1051-1058. PubMed ID: 30269327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment Microvessel Density for Predicting of Tumor Responsiveness to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer.
    Boonya-Ussadorn C; Nimmanon T; Anannamcharoen S
    Asian Pac J Cancer Prev; 2023 Aug; 24(8):2697-2703. PubMed ID: 37642056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic role of TCF4 expression in locally advanced rectal cancer patients treated with neoadjuvant chemoradiotherapy.
    Dou X; Wang R; Meng X; Yan H; Jiang S; Zhu K; Xu X; Chen D; Song X; Mu D
    Cancer Biomark; 2015; 15(2):181-8. PubMed ID: 25519018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of tumor-infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer.
    Matsutani S; Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Hirakawa K; Ohira M
    Cancer Sci; 2018 Apr; 109(4):966-979. PubMed ID: 29464828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vimentin and tumor-stroma ratio for neoadjuvant chemoradiotherapy response prediction in locally advanced rectal cancer.
    Tian W; Yang Y; Qin Q; Zhang L; Wang Z; Su L; Zeng L; Chen H; Hu L; Hong J; Huang Y; Zhang Q; Zhao H
    Cancer Sci; 2023 Feb; 114(2):619-629. PubMed ID: 36221784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
    Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
    [No Abstract]   [Full Text] [Related]  

  • 12. Density of CD8+ lymphocytes in biopsy samples combined with the circulating lymphocyte ratio predicts pathologic complete response to chemoradiotherapy for rectal cancer.
    Xiao B; Peng J; Zhang R; Xu J; Wang Y; Fang Y; Lin J; Pan Z; Wu X
    Cancer Manag Res; 2017; 9():701-708. PubMed ID: 29225479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of CD133 in rectal cancer tissues and its relationship with neoadjuvant chemoradiotherapy].
    Li D; Wu H; Feng R; Zhong D; Luo Y; Xiao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jun; 19(6):690-4. PubMed ID: 27353106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local environment in biopsy better predict the pathological response to neoadjuvant chemoradiotherapy in rectal cancer.
    Huang Y; Lou XY; Zhu YX; Wang YC; Zhang L; Liu HL; Wang C; Zhan HM; Cheng ZQ; Tan WY; Wang L; Fan XJ
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30867256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of (18)F-FDG PET/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer.
    Altini C; Niccoli Asabella A; De Luca R; Fanelli M; Caliandro C; Quartuccio N; Rubini D; Cistaro A; Montemurro S; Rubini G
    Abdom Imaging; 2015 Jun; 40(5):1190-202. PubMed ID: 25348731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response assessment of locally advanced rectal cancer after neoadjuvant chemoradiotherapy: Is apparent diffusion coefficient useful on 3 T magnetic resonance imaging?
    Boraschi P; Cervelli R; Donati F; Landi E; Cacciato-Insilla A; Campani D; Caramella D
    Colorectal Dis; 2023 May; 25(5):905-915. PubMed ID: 36638020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a method for digital assessment of tumor regression grade in patients with rectal cancer following neoadjuvant therapy.
    Jepsen DNM; Høeg H; Thagaard J; Walbech JS; Gögenur I; Fiehn AK
    J Pathol Inform; 2022; 13():100152. PubMed ID: 36605115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Treatment Response of Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Using Amide Proton Transfer MRI Combined With Diffusion-Weighted Imaging.
    Chen W; Mao L; Li L; Wei Q; Hu S; Ye Y; Feng J; Liu B; Liu X
    Front Oncol; 2021; 11():698427. PubMed ID: 34277445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Density and distribution of lymphocytes in pretherapeutic rectal cancer and response to neoadjuvant therapy.
    Lai S; Lou X; Fan X; Sun W; Deng Y; Wang J; Huang Y; Dou R
    Gastroenterol Rep (Oxf); 2020 Dec; 8(6):445-452. PubMed ID: 33442477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Predictive value of combination of MRI tumor regression grade and apparent diffusion coefficient for pathological complete remission after neoadjuvant treatment of locally advanced rectal cancer].
    Xu N; Huang FC; Li WL; Luan X; Jiang YM; He B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):359-365. PubMed ID: 33878826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.